Morning Breakouts

Latest KFF Health News Stories

Following Thousands Of Complaints From Women, FDA Puts Restrictions On Bayer’s Birth Control Implant

Morning Briefing

The FDA said only women who read and have the opportunity to sign a brochure about the risks of the device will be able to receive the implant made by Bayer. The move comes two years after the agency ordered the company to place a “black box warning” on the product package.

California Leads Coalition Of States To Intervene In Texas Suit That Challenges Health Law

Morning Briefing

“It is a legally unsound action, and it is a dangerous action for millions of Americans who left the bad days of pre-existing conditions and the inability to get care for their children,” California Attorney General Xavier Becerra said of the Texas lawsuit that is challenging the constitutionality of the health law saying the mandate no longer counts as a tax.

Naloxone Is A Lifesaver For Many, But Its Flaws Have Scientists Calling For New Alternatives

Morning Briefing

Many experts believe “naloxone is being outgunned” in the opioid crisis that’s fueled by potent drugs like fentanyl and carfentanil. In other news, Congress is set to hold more hearings on the epidemic as lawmakers work toward a bill they want to bring to the floor next month.

Americans Urged To Carry Naloxone. So What Is It, Where Can You Get It, And What Do You Do If It Fails?

Morning Briefing

Following the surgeon general’s rare public health advisory, The New York Times offers a look at common questions surrounding the anti-overdose medication. In other news on the epidemic: Congress is wrapping up work on legislation aimed at fighting the crisis; a panel of advisers warns NIH about accepting money from drug manufacturers; a study finds that accidental drug overdoses in Rhode Island have declined; and more.

Pharma’s Defeat In Doughnut Hole Battle Possible Harbinger Of Things To Come For Powerful Industry

Morning Briefing

Despite an intense lobbying push, drugmakers weren’t able to convince lawmakers to let them off the hook for beneficiaries that fall into the doughnut hole, raising questions about the industry’s current clout. Meanwhile, a drug distributor has been accused of illegally pooling leftover cancer medications to sell to providers; Norvatis is buying gene-therapy company AveXis; a powerful pharmaceutical company dabbles in vineyards; and more.

Virginia Republicans’ Resistance To Expanding Medicaid Starting To Crack

Morning Briefing

Two Republican state senators said this week they would accept some form of broader Medicaid benefits. The issue has sparked a fiery debate in the state, with the Senate blocking the House’s attempts to expand the program. Lawmakers are holding a special session to try to resolve the fight.

Medical Device Industry Could Be Hit Hard By Potential China Tariffs

Morning Briefing

A growing number of products, as well as their components, are now manufactured in China. One report estimated that if the proposed 25 percent tariffs took effect, the move could cost the medical device industry up to $1.5 billion each year.

As States Struggle To Contain Soaring Premiums, Some Looks To Minnesota’s Success With Reinsurance Pool

Morning Briefing

Reinsurance is geared toward helping insurance companies protect themselves when they are hit by an unexpectedly high claim, which helps lower premiums for consumers. But Minnesota’s fix, while successful, is just temporary for now. Meanwhile, voters continue to rank health care as a top issue for the upcoming midterms.